Published online
doi:10.1084/jem.20061400
The Journal of Experimental Medicine, Vol. 204, No. 2, 393-403
The Rockefeller University Press, 0022-1007 $30.00
© Andersen-Nissen et al.
A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin
Erica Andersen-Nissen1,2,
Kelly D. Smith1,3,
Richard Bonneau4,5,
Roland K. Strong2,6, and
Alan Aderem1
1 Institute for Systems Biology, Seattle, WA 98103
2 Department of Immunology and 3 Department of Pathology, University of Washington, Seattle, WA 98195
4 Biology Department and 5 Courant Computer Science Department, New York University, New York, NY 10003
6 Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109
CORRESPONDENCE Alan Aderem: aderem{at}systemsbiology.org
The molecular basis for Toll-like receptor (TLR) recognition of microbial ligands is unknown. We demonstrate that mouse and human TLR5 discriminate between different flagellins, and we use this difference to map the flagellin recognition site on TLR5 to 228 amino acids of the extracellular domain. Through molecular modeling of the TLR5 ectodomain, we identify two conserved surface-exposed regions. Mutagenesis studies demonstrate that naturally occurring amino acid variation in TLR5 residue 268 is responsible for human and mouse discrimination between flagellin molecules. Mutations within one conserved surface identify residues D295 and D367 as important for flagellin recognition. These studies localize flagellin recognition to a conserved surface on the modeled TLR5 structure, providing detailed analysis of the interaction of a TLR with its ligand. These findings suggest that ligand binding at the ß sheets results in TLR activation and provide a new framework for understanding TLRagonist interactions.
Abbreviations used: HA, hemagglutinin; LRR, leucine-rich repeat; TLR, Toll-like receptor.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
-
O'Neill, L. A. J., Bryant, C. E., Doyle, S. L.
(2009). Therapeutic Targeting of Toll-Like Receptors for Infectious and Inflammatory Diseases and Cancer. Pharmacol. Rev.
61: 177-197
[Abstract]
[Full Text]
-
Wlasiuk, G., Khan, S., Switzer, W. M., Nachman, M. W.
(2009). A History of Recurrent Positive Selection at the Toll-Like Receptor 5 in Primates. Mol Biol Evol
26: 937-949
[Abstract]
[Full Text]
-
Walsh, C., Gangloff, M., Monie, T., Smyth, T., Wei, B., McKinley, T. J., Maskell, D., Gay, N., Bryant, C.
(2008). Elucidation of the MD-2/TLR4 Interface Required for Signaling by Lipid IVa. J. Immunol.
181: 1245-1254
[Abstract]
[Full Text]
-
Hood, L., Rowen, L., Galas, D. J., Aitchison, J. D.
(2008). Systems biology at the Institute for Systems Biology. Brief Funct Genomic Proteomic
7: 239-248
[Abstract]
[Full Text]
-
Mizgerd, J. P., Skerrett, S. J.
(2008). Animal models of human pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol.
294: L387-L398
[Abstract]
[Full Text]
-
Kojima, K, Ueta, M, Hamuro, J, Hozono, Y, Kawasaki, S, Yokoi, N, Kinoshita, S
(2008). Human conjunctival epithelial cells express functional Toll-like receptor 5. Br J Ophthalmol
92: 411-416
[Abstract]
[Full Text]
-
Sun, Y.-H., Rolan, H. G., Tsolis, R. M.
(2007). Injection of Flagellin into the Host Cell Cytosol by Salmonella enterica Serotype Typhimurium. J. Biol. Chem.
282: 33897-33901
[Abstract]
[Full Text]
-
Saha, S., Takeshita, F., Matsuda, T., Jounai, N., Kobiyama, K., Matsumoto, T., Sasaki, S., Yoshida, A., Xin, K.-Q., Klinman, D. M., Uematsu, S., Ishii, K. J., Akira, S., Okuda, K.
(2007). Blocking of the TLR5 Activation Domain Hampers Protective Potential of Flagellin DNA Vaccine. J. Immunol.
179: 1147-1154
[Abstract]
[Full Text]